System integrates phenotypic and genomic information at massive scale to define heterogeneity in cell populations, accelerate research, drug discovery and drug development DURHAM, N.C.–Celldom, Inc. today announced that it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health’s National Institute of General Medical Sciences […]

Proteins are the building blocks of life. They form the structure of cells, regulate cellular activity and carry out the biochemical processes that underpin function in every living organism. To understand proteins and their function, we must understand the way they fold, aggregate and interact. Fluidic Analytics Ltd, Cambridge UK, has announced the global launch […]

BURLINGAME, Calif. – Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow. VECTASHIELD Vibrance produces increased brightness over the entire visible spectrum, including far-red fluorophores, compared to existing mounting-media offerings. VECTASHIELD Vibrance produces […]

Visiopharm Phenomap software presented at the Fluidigm Imaging Mass Cytometry User Group Meeting, expanding the suite of Hyperion Imaging System data analysis tools for translational and clinical research  SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) and Visiopharm A/S today announced a co-marketing relationship to automate image analysis for Imaging Mass Cytometry™ (IMC™). Under the terms of this […]

3D imaging technology provides images of the cell cluster down to the nuclei while mitigating drug discovery risks Above: NoviSight™ 3D Cell Analysis Software intuitive user interface provides recognition, analysis, and statistical results in one convenient location Bottom Left: An example image of cancer remodeling (Invasion Level; High)  Bottom Right: 3D detection result of nuclei in 200um spheroid […]

SAN DIEGO – Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, today announced plans to relocate and expand its TriLink BioTechnologies operations with the signing of a lease on a new facility in the Sorrento Valley area of San Diego. TriLink will consolidate its San Diego facilities into a new 95,000-square-foot […]

Dublin/Ireland – ERS Genomics announced today that the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”) has upheld the decision by the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (“PTAB”) to terminate the interference between certain CRISPR/Cas9 patent claims owned by the Regents of the University of California, the University […]

BGI and Children’s Hospital of Philadelphia partner to expand one of the largest genomic data generation efforts for pediatric cancers and structural birth defects PHILADELPHIA, PA – Global genomics leader BGI is collaborating with the Gabriella Miller Kids First Data Resource Center at Children’s Hospital of Philadelphia (CHOP) on a new pediatric research initiative to understand the genetic causes of […]

Cambridge, Mass. Seven Bridges, the leading biomedical data platform and analytics company, today announced the launch of the new Kids First Data Resource Portal with the Gabriella Miller Kids First Data Resource Center (DRC) at the Center for Data Driven Discovery in Biomedicine (D3b) at Children’s Hospital of Philadelphia. The Gabriella Miller Kids First Data Resource Center is a new, collaborative, pediatric research […]

Former Chief Operations Officer and Delta™ System developer Ariel Notcovich promoted to drive industry adoption of the company’s core biomolecule characterization platform SOUTH SAN FRANCISCO, Calif. – Biodesy, Inc., a next-generation biomolecule characterization company, today announced the promotion of Ariel G. Notcovich to Chief Executive Officer, and the completion of a $20 million Series C financing. […]